Sara Omlid, PhD
Partnering Executive, AtomWise
Sara Omlid, Phd is a Partnering Executive at Atomwise Inc., a biotechnology company in San Francisco that uses artificial intelligence for preclinical drug discovery and development.
Atomwise partners with companies and academic institutions on hit discovery and lead optimization projects. Dr. Omlid manages Atomwise’s successful and rapidly growing Artificial Intelligence Molecular Screen (AIMS) Awards program, which provides AI-powered virtual screening and compounds for testing to over a hundred academic researchers across the world each year.
Prior to joining Atomwise, Dr. Omlid was developing new chemistries to add to the medicinal chemist’s toolbox. She also has experience in management consulting in the biotech and life sciences industry. Dr. Omlid received her PhD and MS in physical organic chemistry as well as her bachelor’s degree in biochemistry from Saint Louis University.